K171184 is an FDA 510(k) clearance for the Persyst Mobile App. This device is classified as a Automatic Event Detection Software For Full-montage Electroencephalograph (Class II - Special Controls, product code OMB).
Submitted by Persyst Development Corporation (Solana Beach, US). The FDA issued a Cleared decision on September 21, 2017, 150 days after receiving the submission on April 24, 2017.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User.